Frances McCay
Critical Care Medicine · Memphis, TNNPI 1194984559
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novartis at 34.6% of the total.
Across 276 payments — averaging $14.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Amgen$724
- Heartflow, Inc.$262
- Boehringer Ingelheim$219
- Cvrx, Inc.$200
- Johnson & Johnson$194
- plus $975 from 17 others
What the payments were for
- Food & beverage$3,938100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 132 | $1,362 |
| Amgen | 54 | $724 |
| Heartflow, Inc. | 2 | $262 |
| Boehringer Ingelheim | 14 | $219 |
| Cvrx, Inc. | 2 | $200 |
| Johnson & Johnson | 13 | $194 |
| Pfizer | 10 | $181 |
| Merck | 10 | $143 |
| Bayer | 8 | $115 |
| AstraZeneca | 6 | $99 |
| E.r. Squibb & Sons, L.L.C. | 5 | $90 |
| Impulse Dynamics (USA) Inc. | 4 | $62 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Amarin Pharma, Inc. | 2 | $25 |
| Novo Nordisk | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Abbott | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$245
- Barostim Neo System$181
How this compares
$3,938 in reported general payments places this provider in the 75th percentile of 141 critical care medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $65,128 |
| Ranolazine ErRanolazine | 11 | $5,655 |
| Ezetimibe | 69 | $1,886 |
| Rosuvastatin Calcium | 108 | $1,761 |
| Atorvastatin Calcium | 91 | $1,104 |
| Metoprolol Succinate | 73 | $970 |
| Losartan Potassium | 52 | $933 |
| Amlodipine Besylate | 88 | $747 |
| Hydralazine Hcl | 33 | $690 |
| Olmesartan Medoxomil | 26 | $502 |
| Carvedilol | 39 | $421 |
| Telmisartan | 24 | $380 |
| Pravastatin Sodium | 13 | $257 |
| ClopidogrelClopidogrel Bisulfate | 26 | $250 |
| Torsemide | 13 | $235 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $181 | $65,12867 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 141 critical care medicine providers in Tennessee.
Other critical care medicine in Memphis
- Anthony MattoxMemphis$33K
- Nathan WildsMemphis$19K
- Robert AguillardMemphis$11K
- Kimberly MarshMemphis$11K
- Paul DeatonMemphis$10K
- Garrettson EllisMemphis$9K
- Roy FoxMemphis$9K
- Matthew MabieMemphis$7K
- Steven WoodsMemphis$6K
- William RichardsMemphis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.